Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 5Ovarian Neoplasms 3Small Cell Lung Carcinoma 2Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Fallopian Tube Neoplasms 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Rectal Diseases 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Digestive System Neoplasms 1Digestive System Diseases 1Colorectal Neoplasms 1Colonic Diseases 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 4Oxaliplatin 3Leucovorin 3Irinotecan 3Bevacizumab 35,10-methylenetetrahydrofolic acid 3Colonoscopy 2Capecitabine 2Bisacodyl 2trametinib 1spartalizumab 1pralsetinib 1nazartinib 1napabucasin 1guadecitabine 1canakinumab 1Ursodeoxycholic Acid 1Tinzaparin 1Suction 1Simvastatin 1Radiotherapy 1Polyethylene Glycols 1Pemetrexed 1Oviposition 1Ocoxin 1Mass Screening 1Levoleucovorin 1Drainage 1Cyclophosphamide 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Intestinal Neoplasms × guadecitabine × Clear all
NCT01966289 2021-03-30

SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed
18 enrolled
Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡